Caris Life Sciences price to book ratio CAI

Market value divided by the book value of the company's net assets, since 2025.

Today, Oct 23, 2026: 15.3×
Peer median: 3.6×

Caris Life Sciences' price to book ratio is 15.3× as of Oct 23, 2026.

The median for 10 diagnostics and research stocks of a similar size is 3.6×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	15.3×	6.9×	16.8×
2025	16.7×	14.1×	24.4×

Against its peers

Companies in Medical - Diagnostics & Research nearest Caris Life Sciences' size, closest first, today.

Company	Price to book ratio
CAICaris Life Sciences	15.3×
BIOBio-Rad Laboratories	1.4×
LNTHLantheus	5.0×
BLLNBillionToOne	9.5×
RVTYRevvity	2.5×
MEDPMedpace	43.1×
VCYTVeracyte	2.8×
CDNACareDx	8.4×
LHLabcorp	3.1×
DGXQuest Diagnostics	3.6×
MTDMettler-Toledo International	n/m
Peer median	3.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Caris Life Sciences

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.